Abcelex Technologies Inc
AbCelex Technologies is a privately-owned Canadian biotechnology company that has developed a proprietary camelid antibody platform and has engineered and tested an orally available class of antibodies in two infectious disease programs with proof of concept studies completed. AbCelex has demonstrated successful expression of more than 50 diverse protein target antigens, generated more than 10 large functional libraries of immune and naïve origin. Our platform enables to rationally design and optimise discovery and therapeutic candidates with extended half-live, increased proteolytic stability, and tailored target binding affinity. Additionally, the ability to interchange antibody subunits, AbCelex can rapidly and efficiently create multi-specific and multivalent therapeutic agents suitable for a range of therapeutic applications. Company currently has one immuno-recruiting platform in early preclinical development.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
3
11 to 50 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Abcelex Technologies Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Abcelex Technologies Inc
2 distinct titles indexed · top 2 shown.
- 2scientist
- 1intern
Sign up to unlock all 4 contacts at Abcelex Technologies Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Abcelex Technologies Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.